Status:
RECRUITING
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
Lead Sponsor:
Inova Health Care Services
Conditions:
Solid Tumor
Hematological Malignancy
Eligibility:
All Genders
18+ years
Brief Summary
A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.
Detailed Description
Modern-day wearable devices, such as Apple Watches or Fitbits, are widely available, non-invasive, and can provide continuous vital sign monitoring for the early detection of potential health complica...
Eligibility Criteria
Inclusion
- Planned to be treated with a new cytotoxic chemotherapy or chemoimmunotherapy regimen for a solid tumor or malignant hematology condition for at least 4 months
- ECOG performance status of 0-2
- Age of 18 or older patient with any solid tumor or hematologic malignancy
- English or Spanish speaker
- Own an Apple iPhone
- Capacity and willingness to provide informed consent
Exclusion
- Patients undergoing concurrent radiation since they will be seen on a daily basis by clinic care teams and are not likely to benefit from active remote patient monitoring
- Patients unwilling or unable to comply with the protocol, including wearing the Apple Watch (including recharging daily) and answering queries on the Locus Health iPhone application per the protocol and study group cadence
- Any condition for which in the Investigator's opinion would limit compliance with study requirements
Key Trial Info
Start Date :
October 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 26 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06106360
Start Date
October 26 2023
End Date
June 26 2026
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inova Schar Cancer Institute
Fairfax, Virginia, United States, 22031